Company
Kyverna Therapeutics, Inc. (KYTX)
Standardized SEC financial data for Kyverna Therapeutics, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001994702 · NASDAQ · Biological Products, (No Diagnostic Substances).
Return on equity
-69.5%
Free cash flow
-$153.7M
Current ratio
7.75×
EPS (diluted)
$-3.64
Income statement
| USD | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| R&D expense | $49.9M | $112.5M | $133.7M |
| SG&A expense | $12.5M | $30.1M | $36.1M |
| Operating income | -$62.4M |
Balance sheet
| USD | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Cash & equivalents | — | $34.6M | $286.0M | $279.3M |
| Total current assets | — | $60.7M | $290.6M | $283.0M |
Cash flow
| USD | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Operating cash flow | -$52.4M | -$114.3M | -$153.7M |
| Capital expenditures | $621K | $2.2M | $5K |
| Free cash flow | -$53.0M | -$116.5M |
Get KYTX data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/KYTX/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/KYTX/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"